Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Neurology"
DOI: 10.1007/s00415-022-11025-x
Abstract: Diagnostic criteria for a progressive dysexecutive syndrome due to Alzheimer's disease (dAD) were proposed. Clinical observations suggest substantial variability in the clinico-radiological profiles within this syndrome. We report a case series of 6 patients with…
read more here.
Keywords:
syndrome due;
dysexecutive syndrome;
clinical cases;
progressive dysexecutive ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.862369
Abstract: Second-generation anti-amyloid monoclonal antibodies are emerging as a viable therapeutic option for individuals with prodromal and mild dementia due to Alzheimer's disease (AD). Passive immunotherapy with aducanumab (Aduhelm), lecanemab, donanemab, and gantenerumab all lower CNS…
read more here.
Keywords:
dementia due;
due alzheimer;
disease;
aria ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Brain Sciences"
DOI: 10.3390/brainsci13020244
Abstract: The early identification of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD), in an early stage of AD can expand the AD warning window. We propose a new capability index evaluating the spatial execution…
read more here.
Keywords:
mci due;
due alzheimer;
mild cognitive;
alzheimer disease ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Diagnostics"
DOI: 10.3390/diagnostics11010108
Abstract: Semantic cues in the Free and Cued Selective Reminding Test (FCRST) play a key role in the neuropsychological diagnosis of Amnesic Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD); however, the neural bases of their…
read more here.
Keywords:
mci;
cognitive impairment;
due alzheimer;
impairment due ... See more keywords